Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT05725018Phase 3Active Not Recruiting
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients
Epidermolysis BullosaRDEBRecessive Dystrophic Epidermolysis Bullosa
StudydirectorStart date: 2023-04-02

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Abeona Therapeutics, Inc

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Angela Iheanacho, MS

Abeona Therapeutics, Inc

Moderately Similar
2 trials

Shared therapeutic areas:

RDEBEpidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa

Worked with same sponsors:

Abeona Therapeutics, Inc
Collaborated on 2 trials
Similarity Score38%

Elena Pope, MD, FRCPC

The Hospital for Sick Children

Related
1 trials

Shared therapeutic areas:

RDEBRecessive Dystrophic Epidermolysis Bullosa
Similarity Score20%

Jean Tang, MD

Stanford University

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa

Worked with same sponsors:

Abeona Therapeutics, Inc
Similarity Score20%

Lucie Germain, PhD

CHU de Québec-Université Laval

Related
1 trials

Shared therapeutic areas:

RDEBRecessive Dystrophic Epidermolysis Bullosa
Similarity Score20%

Matt P Marinkovich, MD

Associate Professor of Dermatology

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Similarity Score20%

Amy S Paller, MD

Northwestern University

Related
4 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score10%

Jean Y Tang, PhD

Stanford University

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score10%

Mary Spellman

Castle Creek Pharmaceuticals, LLC

Related
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score10%

Sarah Chaumon

Assistance Publique - Hôpitaux de Paris

Related
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05725018Phase 3StudyDirector

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

Epidermolysis BullosaRDEBRecessive Dystrophic Epidermolysis Bullosa
Active Not Recruiting
NCT05708677StudyDirector

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

RDEB
Enrolling By Invitation

All 2 trials loaded